EFITAZANAMIVIR ALFA
UNII 7CA5JND7QE

Substance Identification & Data

This profile provides standardized clinical and technical data for Efitazanamivir Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7CA5JND7QE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2781830-14-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
7CA5JND7QE
CAS Registry Number
2781830-14-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EFITAZANAMIVIR ALFA
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C220988
National Cancer Institute reference terminology for clinical and research data.
INN ID
13066
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Efitazanamivir Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EFITAZANAMIVIR ALFA

Common Names & Synonyms

84-329-IMMUNOGLOBULIN G1 (135-TYROSINE,137-THREONINE,139-GLUTAMIC ACID) (HUMAN .GAMMA.1-CHAIN CONSTANT REGION), DIMER, N6-(15-(4-(20-CARBOXY-14-(2-(2-(CARBOXYMETHYLAMINO)ETHOXY)ETHYL)-2,5,8,11,17-PENTAOXA-14,20-DIAZAHENEICOS-1-YL)-1H-1,2,3-TRIAZOL-1-YL)-1-OXO-4,7,10,13-TETRAOXAPENTADEC-1-YL)-L-LYSINE, 7,7'-DIESTER WITH 5-(ACETYLAMINO)-2,6-ANHYDRO-4-((AMINOIMINOMETHYL)AMINO)-3,4,5-TRIDEOXY-D-GLYCERO-D-GALACTO-NON-2-ENONIC ACID
EFITAZANAMIVIR ALFA [INN]
FC FRAGMENT OF HUMAN IMMUNOGLOBULIN G1 (1-247) (HOMO SAPIENS IGHG1*01(CH1 FINAL 15 RESIDUES (1-15), HINGE (16-30), CH2 M52>Y, S54>T, T56>E (31-140), CH3 (141-245), CHS (246-247))), DIMER (26-26':29-29')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA; SUBSTITUTED ON AN AVERAGE OF 4 TO 5 LLYSINE RESIDUES AT N6 WITH RADICAL GROUP 1-(4-((23R,24R)-23-((2R,3R,4S)-3-ACETAMIDO-4-(CARBAMIMIDOYLAMINO)-6-CARBOXY-3,4-DIHYDRO-2H-PYRAN-2-YL)-14-(2-(2-((((1R,2R)-1-((2R,3R,4S)-3-ACETAMIDO-4-(CARBAMIMIDOYLAMINO)-6-CARBOXY-3,4-DIHYDRO-2H-PYRAN-2-YL)-2,3-DIHYDROXYPROPOXY)CARBONYL)(METHYL)AMINO)ETHOXY)ETHYL)-24,25-DIHYDROXY-20-METHYL-21-OXO-2,5,8,11,17,22-HEXAOXA-14,20-DIAZAPENTACOSAN-1-YL)-1H-1,2,3-TRIAZOL-1-YL)-3,6,9,12-TETRAOXAPENTADECAN-15-OYL

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus